NWI Management »

Ambrx Biopharma shares owned by NWI Management

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by NWI Management from 13F filings

Historical chart of NWI Management investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by NWI Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by NWI Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $764k 54k 14.24

More positions owned by NWI Management

January 24 Calls On Spy Us Call Call Option
February 24 Puts On Spy Us Put Put Option
January 24 Calls On Msft Us Call Call Option
March 24 Puts On Qqq Us Put Put Option
NVIDIA Corporation (NVDA)
January 25 Calls On Cvx Us Call Call Option
January 24 Calls On Goog Us Call Call Option
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
March 24 Puts On Aapl Us Put Put Option
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Meta Platforms Inc-class A Cl A (META)
Intercorp Financial Services SHS (IFS)
Palo Alto Networks (PANW)
Advanced Micro Devices (AMD)

View all positions for NWI Management

Top funds holding Ambrx Biopharma

Darwin Global Management
Cormorant Asset Management
Paradigm Biocapital Advisors
D. E. Shaw & Co
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Logos Global Management
VR Adviser
Vanguard Group
T. Rowe Price Associates
WuXi AppTec
Millennium Management
Goldman Sachs Group
Federated Investors

View all funds holding Ambrx Biopharma